Browsing by Subject "Current perspectives"
Now showing items 1-1 of 1
-
(Hindawi, 2018)Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism ...